Novoron Bioscience

company

About

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology,Neuroscience,Pharmaceutical
Founded date
Feb 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Novoron Bioscience develops novel therapeutic approaches for the treatment of disorders of the central nervous system. The company has made proprietary scientific discoveries in treatment of various pathologies of the central nervous system and is advancing a pipeline of biologic therapeutics for multiple sclerosis, spinal cord injury and glaucoma. Novoron is a Delaware C-corp headquartered in San Diego, California and is part of the JLABS innovation community.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Novoron Bioscience has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 28, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 28, 2022 Grant 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Novoron Bioscience is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant